60 DEGREES PHARMACEUTICALS, INC.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Sep 30 2023

Q: Jun 30 2023

Other Events

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Other Events

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Other Events

Other Events

Other Events

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Other Events

Notice of Effectiveness

No description available

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

<ITEMS>06b

<ITEMS>06b

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Definitive Proxy Statement

Preliminary Proxy Statement

Required Information in Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Lind Global Fund III LP

Knight Therapeutics Inc.

Knight Therapeutics Inc.

DOW GEOFFREY S

Francois Eric

CVI Investments, Inc.

Knight Therapeutics Inc.

INTRACOASTAL CAPITAL, LLC

DOW GEOFFREY S

DOW GEOFFREY S

Ayrton Capital LLC

CVI Investments, Inc.

INTRACOASTAL CAPITAL, LLC

DOW GEOFFREY S

Landon Kristen

Landon Kristen

Landon Kristen

CVI Investments, Inc.

INTRACOASTAL CAPITAL, LLC

Orca Capital AG

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

No description available

Correspondence with the SEC

Correspondence with the SEC